Interaction Checker

Pembrolizumab – now available on the interaction checker

Monday 05 February 2018

Pembrolizumab is now listed in the interaction checker as a cancer drug and interactions can be found with all the comedications. 

Pembrolizumab (Keytruda®) is a monoclonal antibody and is indicated for the treatment of melanoma, non-small cell lung cancer and Hodgkin disease.

ENDORSED BY
Bopa